ID   PI42B_HUMAN             Reviewed;         416 AA.
AC   P78356; Q5U0E8; Q8TBP2;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Phosphatidylinositol 5-phosphate 4-kinase type-2 beta;
DE            EC=2.7.1.149;
DE   AltName: Full=1-phosphatidylinositol 5-phosphate 4-kinase 2-beta;
DE   AltName: Full=Diphosphoinositide kinase 2-beta;
DE   AltName: Full=Phosphatidylinositol 5-phosphate 4-kinase type II beta;
DE            Short=PI(5)P 4-kinase type II beta;
DE            Short=PIP4KII-beta;
DE   AltName: Full=PtdIns(5)P-4-kinase isoform 2-beta;
GN   Name=PIP4K2B; Synonyms=PIP5K2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   TNFRSF1A, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9038203; DOI=10.1074/jbc.272.9.5861;
RA   Castellino A.M., Parker G.J., Boronenkov I.V., Anderson R.A.,
RA   Chao M.V.;
RT   "A novel interaction between the juxtamembrane region of the p55 tumor
RT   necrosis factor receptor and phosphatidylinositol-4-phosphate 5-
RT   kinase.";
RL   J. Biol. Chem. 272:5861-5870(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION WITH PIP4K2A, SUBCELLULAR
RP   LOCATION, UBIQUITINATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20583997; DOI=10.1042/BJ20100341;
RA   Bultsma Y., Keune W.-J., Divecha N.;
RT   "PIP4Kbeta interacts with and modulates nuclear localization of the
RT   high-activity PtdIns5P-4-kinase isoform PIP4Kalpha.";
RL   Biochem. J. 430:223-235(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 34-416, AND HOMODIMERIZATION.
RX   PubMed=9753329; DOI=10.1016/S0092-8674(00)81741-9;
RA   Rao V.D., Misra S., Boronenkov I.V., Anderson R.A., Hurley J.H.;
RT   "Structure of type IIbeta phosphatidylinositol phosphate kinase: a
RT   protein kinase fold flattened for interfacial phosphorylation.";
RL   Cell 94:829-839(1998).
CC   -!- FUNCTION: Participates in the biosynthesis of phosphatidylinositol
CC       4,5-bisphosphate. {ECO:0000269|PubMed:9038203}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 5-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=30 uM for phosphatidylinositol-5- phosphate
CC         {ECO:0000269|PubMed:20583997};
CC         Vmax=0.2 pmol/min/ug enzyme {ECO:0000269|PubMed:20583997};
CC   -!- SUBUNIT: Homodimer. Binds TNFRSF1A. Interacts with PIP4K2A.
CC       Interaction with PIP4K2A suppresses ubiquitination by the SPOP/
CC       CUL3 complex. {ECO:0000269|PubMed:20583997,
CC       ECO:0000269|PubMed:9038203}.
CC   -!- INTERACTION:
CC       Q6NT76:HMBOX1; NbExp=5; IntAct=EBI-947090, EBI-2549423;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell
CC       membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Nucleus {ECO:0000269|PubMed:20583997}. Cytoplasm
CC       {ECO:0000269|PubMed:20583997}. Note=Associated with the plasma
CC       membrane and the endoplasmic reticulum. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78356-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78356-2; Sequence=VSP_010384, VSP_010385;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, heart, pancreas,
CC       skeletal muscle and kidney. Detected at lower levels in placenta,
CC       lung and liver. {ECO:0000269|PubMed:9038203}.
CC   -!- PTM: Ubiquitinated by the SPOP/CUL3 complex. Ubiquitination is
CC       stimulated by PtdIns5P levels. {ECO:0000269|PubMed:20583997}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U85245; AAB48596.1; -; mRNA.
DR   EMBL; BT019614; AAV38420.1; -; mRNA.
DR   EMBL; BC027459; AAH27459.1; -; mRNA.
DR   CCDS; CCDS11329.1; -. [P78356-1]
DR   RefSeq; NP_003550.1; NM_003559.4. [P78356-1]
DR   UniGene; Hs.260603; -.
DR   PDB; 1BO1; X-ray; 3.00 A; A/B=1-416.
DR   PDB; 3WZZ; X-ray; 2.60 A; A/B=31-416.
DR   PDB; 3X01; X-ray; 2.15 A; A/B=31-416.
DR   PDB; 3X02; X-ray; 2.45 A; A/B=31-416.
DR   PDB; 3X03; X-ray; 2.70 A; A/B=31-416.
DR   PDB; 3X04; X-ray; 2.60 A; A/B=31-416.
DR   PDB; 3X05; X-ray; 2.50 A; A/B=31-416.
DR   PDB; 3X06; X-ray; 2.65 A; A/B=31-416.
DR   PDB; 3X07; X-ray; 2.60 A; A/B=31-416.
DR   PDB; 3X08; X-ray; 2.75 A; A/B=31-416.
DR   PDB; 3X09; X-ray; 2.70 A; A/B=31-416.
DR   PDB; 3X0A; X-ray; 2.60 A; A/B=31-416.
DR   PDB; 3X0B; X-ray; 2.60 A; A/B=31-416.
DR   PDB; 3X0C; X-ray; 2.55 A; A/B=31-416.
DR   PDBsum; 1BO1; -.
DR   PDBsum; 3WZZ; -.
DR   PDBsum; 3X01; -.
DR   PDBsum; 3X02; -.
DR   PDBsum; 3X03; -.
DR   PDBsum; 3X04; -.
DR   PDBsum; 3X05; -.
DR   PDBsum; 3X06; -.
DR   PDBsum; 3X07; -.
DR   PDBsum; 3X08; -.
DR   PDBsum; 3X09; -.
DR   PDBsum; 3X0A; -.
DR   PDBsum; 3X0B; -.
DR   PDBsum; 3X0C; -.
DR   DisProt; DP00054; -.
DR   ProteinModelPortal; P78356; -.
DR   SMR; P78356; -.
DR   BioGrid; 113985; 32.
DR   IntAct; P78356; 8.
DR   MINT; MINT-2864974; -.
DR   STRING; 9606.ENSP00000269554; -.
DR   BindingDB; P78356; -.
DR   ChEMBL; CHEMBL5667; -.
DR   GuidetoPHARMACOLOGY; 2162; -.
DR   iPTMnet; P78356; -.
DR   PhosphoSitePlus; P78356; -.
DR   BioMuta; PIP4K2B; -.
DR   DMDM; 47605991; -.
DR   EPD; P78356; -.
DR   MaxQB; P78356; -.
DR   PaxDb; P78356; -.
DR   PeptideAtlas; P78356; -.
DR   PRIDE; P78356; -.
DR   DNASU; 8396; -.
DR   Ensembl; ENST00000613180; ENSP00000480776; ENSG00000277292. [P78356-1]
DR   Ensembl; ENST00000619039; ENSP00000482548; ENSG00000276293. [P78356-1]
DR   GeneID; 8396; -.
DR   KEGG; hsa:8396; -.
DR   UCSC; uc002hqs.4; human. [P78356-1]
DR   CTD; 8396; -.
DR   DisGeNET; 8396; -.
DR   GeneCards; PIP4K2B; -.
DR   HGNC; HGNC:8998; PIP4K2B.
DR   HPA; HPA047875; -.
DR   HPA; HPA062220; -.
DR   MIM; 603261; gene.
DR   neXtProt; NX_P78356; -.
DR   OpenTargets; ENSG00000276293; -.
DR   PharmGKB; PA162399640; -.
DR   eggNOG; KOG0229; Eukaryota.
DR   eggNOG; COG5253; LUCA.
DR   GeneTree; ENSGT00760000119184; -.
DR   HOGENOM; HOG000007832; -.
DR   HOVERGEN; HBG000072; -.
DR   InParanoid; P78356; -.
DR   KO; K00920; -.
DR   OMA; ECENDGL; -.
DR   OrthoDB; EOG091G0857; -.
DR   PhylomeDB; P78356; -.
DR   TreeFam; TF354315; -.
DR   BRENDA; 2.7.1.149; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-6811555; PI5P Regulates TP53 Acetylation.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8847453; Synthesis of PIPs in the nucleus.
DR   SABIO-RK; P78356; -.
DR   SIGNOR; P78356; -.
DR   ChiTaRS; PIP4K2B; human.
DR   EvolutionaryTrace; P78356; -.
DR   GeneWiki; PIP4K2B; -.
DR   GenomeRNAi; 8396; -.
DR   PRO; PR:P78356; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141720; -.
DR   CleanEx; HS_PIP4K2B; -.
DR   ExpressionAtlas; P78356; baseline and differential.
DR   Genevisible; P78356; HS.
DR   GO; GO:0005776; C:autophagosome; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0052811; F:1-phosphatidylinositol-3-phosphate 4-kinase activity; TAS:Reactome.
DR   GO; GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IDA:MGI.
DR   GO; GO:0016309; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0005057; F:signal transducer activity, downstream of receptor; TAS:ProtInc.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:Reactome.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
DR   Gene3D; 3.30.800.10; -; 1.
DR   Gene3D; 3.30.810.10; -; 1.
DR   InterPro; IPR023610; PInositol-4-P-5-kinase.
DR   InterPro; IPR027483; PInositol-4-P-5-kinase_C.
DR   InterPro; IPR002498; PInositol-4-P-5-kinase_core.
DR   InterPro; IPR027484; PInositol-4-P-5-kinase_N.
DR   PANTHER; PTHR23086; PTHR23086; 1.
DR   Pfam; PF01504; PIP5K; 1.
DR   SMART; SM00330; PIPKc; 1.
DR   PROSITE; PS51455; PIPK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Complete proteome; Cytoplasm; Endoplasmic reticulum;
KW   Kinase; Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    416       Phosphatidylinositol 5-phosphate 4-kinase
FT                                type-2 beta.
FT                                /FTId=PRO_0000185470.
FT   DOMAIN       38    415       PIPK. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00781}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES     150    150       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     322    322       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q80XI4}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ     270    281       FLAQLKIMDYSL -> EILVLSPGRRIA (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010384.
FT   VAR_SEQ     282    416       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010385.
FT   CONFLICT    250    250       L -> P (in Ref. 2; AAV38420).
FT                                {ECO:0000305}.
FT   HELIX        41     57       {ECO:0000244|PDB:3X01}.
FT   HELIX        68     72       {ECO:0000244|PDB:3X01}.
FT   STRAND       74     82       {ECO:0000244|PDB:3X01}.
FT   STRAND       87     89       {ECO:0000244|PDB:3X01}.
FT   STRAND       91     99       {ECO:0000244|PDB:3X01}.
FT   HELIX       100    109       {ECO:0000244|PDB:3X01}.
FT   HELIX       114    122       {ECO:0000244|PDB:3X01}.
FT   STRAND      133    136       {ECO:0000244|PDB:1BO1}.
FT   STRAND      139    141       {ECO:0000244|PDB:3X01}.
FT   STRAND      145    152       {ECO:0000244|PDB:3X01}.
FT   HELIX       154    173       {ECO:0000244|PDB:3X01}.
FT   TURN        174    176       {ECO:0000244|PDB:3X01}.
FT   STRAND      183    191       {ECO:0000244|PDB:3X01}.
FT   STRAND      194    202       {ECO:0000244|PDB:3X01}.
FT   STRAND      207    209       {ECO:0000244|PDB:3X01}.
FT   STRAND      213    217       {ECO:0000244|PDB:3X01}.
FT   STRAND      221    224       {ECO:0000244|PDB:1BO1}.
FT   TURN        228    232       {ECO:0000244|PDB:3X01}.
FT   STRAND      233    235       {ECO:0000244|PDB:3X01}.
FT   STRAND      237    239       {ECO:0000244|PDB:3X01}.
FT   HELIX       240    245       {ECO:0000244|PDB:3X01}.
FT   HELIX       254    273       {ECO:0000244|PDB:3X01}.
FT   STRAND      280    287       {ECO:0000244|PDB:3X01}.
FT   HELIX       288    303       {ECO:0000244|PDB:3X01}.
FT   TURN        344    346       {ECO:0000244|PDB:3X01}.
FT   TURN        347    349       {ECO:0000244|PDB:1BO1}.
FT   STRAND      350    352       {ECO:0000244|PDB:3X01}.
FT   STRAND      353    355       {ECO:0000244|PDB:1BO1}.
FT   STRAND      357    359       {ECO:0000244|PDB:3X02}.
FT   STRAND      361    368       {ECO:0000244|PDB:3X01}.
FT   STRAND      394    396       {ECO:0000244|PDB:1BO1}.
FT   HELIX       401    412       {ECO:0000244|PDB:3X01}.
FT   STRAND      414    416       {ECO:0000244|PDB:3X02}.
SQ   SEQUENCE   416 AA;  47378 MW;  2288CD2883EACEBE CRC64;
     MSSNCTSTTA VAVAPLSASK TKTKKKHFVC QKVKLFRASE PILSVLMWGV NHTINELSNV
     PVPVMLMPDD FKAYSKIKVD NHLFNKENLP SRFKFKEYCP MVFRNLRERF GIDDQDYQNS
     VTRSAPINSD SQGRCGTRFL TTYDRRFVIK TVSSEDVAEM HNILKKYHQF IVECHGNTLL
     PQFLGMYRLT VDGVETYMVV TRNVFSHRLT VHRKYDLKGS TVAREASDKE KAKDLPTFKD
     NDFLNEGQKL HVGEESKKNF LEKLKRDVEF LAQLKIMDYS LLVGIHDVDR AEQEEMEVEE
     RAEDEECEND GVGGNLLCSY GTPPDSPGNL LSFPRFFGPG EFDPSVDVYA MKSHESSPKK
     EVYFMAIIDI LTPYDTKKKA AHAAKTVKHG AGAEISTVNP EQYSKRFNEF MSNILT
//
